Clinical Trials Browser

Phase 2 × HER2 Low Breast Carcinoma × Breast × Clear all

NCT05911958 2024-11-04

A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

Phase 2 Recruiting

HER2 Low Breast Carcinoma